Kaken Pharmaceutical Co., Ltd. (TYO:4521)
Japan · Delayed Price · Currency is JPY 4,255.00
+35.00 (0.83%)
At close: Mar 27, 2026
Kaken Pharmaceutical Market Cap
Kaken Pharmaceutical has a market cap or net worth of 161.13 billion as of March 27, 2026. Its market cap has decreased by -11.51% in one year.
Market Cap
161.13B
Enterprise Value
119.14B
Revenue
75.66B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,255.00
Market Cap Chart
Since March 26, 1993, Kaken Pharmaceutical's market cap has increased from 118.38B to 161.13B, an increase of 36.11%. That is a compound annual growth rate of 0.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 161.13B | 5.98% |
| Dec 30, 2025 | 152.04B | -11.05% |
| Dec 30, 2024 | 170.93B | 34.53% |
| Dec 29, 2023 | 127.05B | -12.84% |
| Dec 30, 2022 | 145.77B | -8.45% |
| Dec 30, 2021 | 159.22B | 3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nippon Shinyaku | 352.51B |
| Toho Holdings | 306.10B |
| Tsumura & Co. | 285.43B |
| Sawai Group Holdings | 253.14B |
| Towa Pharmaceutical | 196.67B |
| Kissei Pharmaceutical | 192.75B |
| Mochida Pharmaceutical | 129.75B |
| KYORIN Pharmaceutical | 95.53B |